These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 27906151)

  • 41. [Evaluation of clinical effectiveness and adverse effects of Polnitrin].
    Kośmicki M; Sadowski Z
    Wiad Lek; 1992 Mar; 45(5-6):165-9. PubMed ID: 1455853
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nitroglycerine tolerance.
    Vine DL
    Kans Med; 1990 Jun; 91(6):187-8. PubMed ID: 2118967
    [No Abstract]   [Full Text] [Related]  

  • 43. [Treatment of patients with angina pectoris in general practice with a new transdermal therapeutic system containing nitroglycerin (author's transl)].
    Garnier B; Imhof P; Spinelli F; Jost H
    Schweiz Rundsch Med Prax; 1982 Mar; 71(12):511-6. PubMed ID: 6806799
    [No Abstract]   [Full Text] [Related]  

  • 44. Nitroglycerin ointment for angina pectoris.
    Med Lett Drugs Ther; 1981 Sep; 23(19):82-3. PubMed ID: 6792478
    [No Abstract]   [Full Text] [Related]  

  • 45. Management of chronic stable angina pectoris.
    Rodríguez-Ospina L; Montano-Soto L
    Bol Asoc Med P R; 2008; 100(4):39-47. PubMed ID: 19400528
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Comparative efficacy, safety, cardio-hemodynamic effects of isosorbide dinitrate (ID) aerosol and sublingual tablets of nitroglycerin].
    Ol'binskaia LI; Sizova ZhM; Ushakova AV
    Ter Arkh; 1998; 70(5):69-72. PubMed ID: 9644750
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The development of tolerance to continuous transdermal nitroglycerin therapy in patients with angina of effort and mixed angina].
    Cianfrocca C; Sabia R; Zoboli S; Bugiardini R
    G Ital Cardiol; 1993 May; 23(5):439-49. PubMed ID: 8339869
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [A trial of the use of the transdermal preparation Deponit for treating stenocardia].
    Alliluev IG; Pecherskaia MB; Poltavskaia MG; Syrkin AL
    Ter Arkh; 1996; 68(6):55-8. PubMed ID: 8771688
    [No Abstract]   [Full Text] [Related]  

  • 49. [Frequency of sublingual nitroglycerin prescription in patients with coronary artery disease and angina and awareness of patients about the shelf life of the drug].
    Yılmaz OC; Keskin G; Cuğlan B; Selçoki Y; Temizkan A; Eryonucu B; Soran O
    Turk Kardiyol Dern Ars; 2011 Sep; 39(6):469-73. PubMed ID: 21918316
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Severe bradycardia and arterial hypotension following the administration of sublingual nitroglycerin].
    Sanz Girgas E; Tornos MP; Permanyer Miralda G; Carner X; Soler Soler J
    Rev Esp Cardiol; 1990; 43(6):403-5. PubMed ID: 2122504
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A multicenter comparison of adhesion, preference, tolerability, and safety characteristics of two transdermal nitroglycerin delivery systems: Transderm-Nitro and Deponit.
    Chinoy DA; Camp J; Elchahal S; Godoy C; Grossman W; Hai H; Hamilton W; Kushner M; McGreevy M; Mulvihill RJ
    Clin Ther; 1989; 11(5):678-84. PubMed ID: 2509071
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Transmucosal and transdermal nitroglycerin delivery systems for prevention of chronic stable angina pectoris.
    Khurmi NS; O'Hara MJ; Bowles MJ; Whittington JR; Lahiri A; Raftery EB
    Br J Clin Pract; 1986 May; 40(5):187-91. PubMed ID: 3092852
    [No Abstract]   [Full Text] [Related]  

  • 53. [Long-term effect of organic nitrates in angina pectoris: dependence on the form of administration and mode of stress].
    Schneider W; Bussmann WD; Kober G; Kaltenbach M
    Z Kardiol; 1989; 78 Suppl 2():83-7; discussion 115-7. PubMed ID: 2531510
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The long-term safety and tolerability of transdermal glyceryl trinitrate, when used with a patch-free interval in patients with stable angina.
    Wainwright RJ; Foran JP; Padaria SF; Akhras F; Jackson G; Clark AR
    Br J Clin Pract; 1993; 47(4):178-82. PubMed ID: 8260332
    [TBL] [Abstract][Full Text] [Related]  

  • 55. How best to use nitrates.
    Desilvio A; Barlattani MP
    Br Med J (Clin Res Ed); 1987 Nov; 295(6607):1163-4. PubMed ID: 3120926
    [No Abstract]   [Full Text] [Related]  

  • 56. Letter: Development of a stable sublingual nitroglycerin tablet I: interaction of nitroglycerin with selected macromolecules.
    Fung HL; Yap SK; Rhodes CT
    J Pharm Sci; 1974 Nov; 63(11):1810-2. PubMed ID: 4214916
    [No Abstract]   [Full Text] [Related]  

  • 57. Symptomatic bradycardia following the administration of sublingual nitroglycerin.
    Buckley R; Roberts R
    Am J Emerg Med; 1993 May; 11(3):253-5. PubMed ID: 8489673
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nitroglycerin and potassium.
    Toole JG; Kleinhenz TJ
    Am J Cardiol; 1986 Apr; 57(11):1003. PubMed ID: 3083666
    [No Abstract]   [Full Text] [Related]  

  • 59. Sublingual nitroglycerin powder (GoNitro).
    Med Lett Drugs Ther; 2016 Dec; 58(1509):156-157. PubMed ID: 27906151
    [No Abstract]   [Full Text] [Related]  

  • 60. Buccal versus sublingual nitroglycerin administration in the treatment of angina pectoris: a multicentre study.
    Rydén L; Schaffrath R
    Eur Heart J; 1987 Sep; 8(9):995-1001. PubMed ID: 3117554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.